- Prestige Consumer Healthcare (PBH, Financial) will release its fiscal 2025 Q4 and year-end earnings on May 8, 2025.
- A conference call to discuss the results will be held at 8:30 a.m. ET on the same day.
- Investors can access the live webcast and replay through the company's Investor Relations page.
Prestige Consumer Healthcare Inc. (PBH) has announced that it will publish its fiscal 2025 fourth quarter and year-end earnings results on Thursday, May 8, 2025, before the market opens. The company will conduct a conference call that morning at 8:30 a.m. Eastern Time to discuss these results.
Investors and interested parties can join the live Internet webcast through the Investor Relations section of the company’s website, prestigeconsumerhealthcare.com. Additionally, phone participation is available with prior registration, and participants are advised to join the call 10 minutes before the start time. A replay of the conference call will be available on the Investor Relations page for approximately one week following the event.
Prestige Consumer Healthcare Inc., known for a diverse portfolio of healthcare products across the United States, Canada, Australia, and other international markets, continues to be a significant entity in the specialty and generic drug manufacturing industry. With a market cap of $3.68 billion and a diverse product line featuring well-known brands like Monistat®, BC®, Clear Eyes®, and many more, the company maintains its pivotal role in the consumer healthcare sector.
